N.J. law designed to address prescription eye drop adherence
TRENTON, N.J. — New Jersey Gov. Chris Christie signed legislation into law Monday that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.
The law, A-3080 — and companion Senate bill S-2166 — requires insurance companies and health plans to cover early refill of prescription eye drops when 70% of a supply’s days of use have passed. For example, a patient with a 30-day supply could obtain a refill after 21 days instead of having to wait for all 30 days. Supporters of the legislation said it was necessary due to the number of people who have difficulty properly administering prescription eye drops for chronic conditions such as glaucoma, which can result in patients missing their eyes or using too many drops.
"Many diseases of the eye are treated with chronic therapy through use of medications," New Jersey Academy of Ophthalmology president Cecily Lesko said. "Glaucoma is the most common. Left untreated, it is one of the leading causes of blindness. With this effort and outcome, proper treatment remains available to more patients who will benefit personally and directly through the treasured gift of sight."
Hillary Clinton to speak at Total Store Expo
ARLINGTON, Va. — Former secretary of state Hillary Clinton will speak at one of the morning business sessions of the National Association of Chain Drug Stores’ Total Store Expo in August, the trade group said Monday.
Clinton, who served as state secretary from 2009 until earlier this year, will speak during the Aug. 12 program. TSE, which will combine the Pharmacy and Technology, Marketplace and Supply Chain and Logistics conferences, will take place in Las Vegas.
"Her remarks will help to deliver on a core promise, that the NACDS Total Store Expo will bring together diverse leaders who can help participants forecast the operating environment and take action toothier in new and exciting ways," NACDS president and CEO Steven Anderson said.
GPhA promotes lobbyist
WASHINGTON — The Generic Pharmaceutical Association has promoted Jason Money to associate VP federal government affairs, the trade group said Monday.
Money, who has worked for the GPhA for six years, was previously the organization’s senior director for federal affairs. In the new position, he will continue lobbying on behalf of the generic drug industry in Congress.
"Jason brings an unmatched passion to GPhA legislative affairs," GPhA president and CEO Ralph Neas said. "We are thrilled to recognize his exceptional work on behalf of an industry helping to ensure that our nation’s policies continue to protect and encourage the important role generics and biosimilars play, bending the health cost curve and improving lives."